DK169364B1 - Fremgangsmåde til måling af niveauet af antigener,antistoffer eller haptener i en flydende prøve - Google Patents

Fremgangsmåde til måling af niveauet af antigener,antistoffer eller haptener i en flydende prøve Download PDF

Info

Publication number: DK169364B1
Authority: DK; Denmark
Prior art keywords: matrix; antibody; antigen; ligand; hapten
Prior art date: 1986-05-12

Application number

DK241787A

Other languages

Danish (da)

English (en)

Other versions

DK241787A (da

DK241787D0 (da

Inventor

Shami A Said El

Olusola O Alaba

Charles A Kasal

Original Assignee

Diagnostic Products Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-05-12

Filing date

1987-05-12

Publication date

1994-10-10

1987-05-12 Application filed by Diagnostic Products Corp filed Critical Diagnostic Products Corp

1987-05-12 Publication of DK241787D0 publication Critical patent/DK241787D0/da

1987-11-13 Publication of DK241787A publication Critical patent/DK241787A/da

1994-10-10 Application granted granted Critical

1994-10-10 Publication of DK169364B1 publication Critical patent/DK169364B1/da

Links

239000000427 antigen Substances 0.000 title claims abstract description 70
102000036639 antigens Human genes 0.000 title claims abstract description 62
108091007433 antigens Proteins 0.000 title claims abstract description 62
238000000034 method Methods 0.000 title claims abstract description 38
239000007788 liquid Substances 0.000 title claims abstract description 22
239000011159 matrix material Substances 0.000 claims abstract description 105
238000006243 chemical reaction Methods 0.000 claims abstract description 93
239000003446 ligand Substances 0.000 claims abstract description 60
239000007791 liquid phase Substances 0.000 claims abstract description 23
239000007787 solid Substances 0.000 claims abstract description 23
239000007790 solid phase Substances 0.000 claims description 32
239000000523 sample Substances 0.000 claims description 28
102000004190 Enzymes Human genes 0.000 claims description 17
108090000790 Enzymes Proteins 0.000 claims description 17
238000002372 labelling Methods 0.000 claims description 12
150000001875 compounds Chemical class 0.000 claims description 9
239000000758 substrate Substances 0.000 claims description 6
239000007850 fluorescent dye Substances 0.000 claims description 4
239000000126 substance Substances 0.000 claims description 4
230000027455 binding Effects 0.000 claims description 3
230000008569 process Effects 0.000 claims description 3
230000002285 radioactive effect Effects 0.000 claims 3
ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 claims 1
230000009137 competitive binding Effects 0.000 claims 1
238000005406 washing Methods 0.000 abstract description 2
239000011616 biotin Substances 0.000 description 44
229960002685 biotin Drugs 0.000 description 44
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 40
239000013566 allergen Substances 0.000 description 40
229920001577 copolymer Polymers 0.000 description 37
229920000656 polylysine Polymers 0.000 description 33
108010039918 Polylysine Proteins 0.000 description 32
235000020958 biotin Nutrition 0.000 description 25
235000018102 proteins Nutrition 0.000 description 25
102000004169 proteins and genes Human genes 0.000 description 25
108090000623 proteins and genes Proteins 0.000 description 25
LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 22
229960004784 allergens Drugs 0.000 description 20
235000001014 amino acid Nutrition 0.000 description 16
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
210000002966 serum Anatomy 0.000 description 15
108090001008 Avidin Proteins 0.000 description 14
206010003645 Atopy Diseases 0.000 description 13
230000002860 competitive effect Effects 0.000 description 12
238000002360 preparation method Methods 0.000 description 11
239000011541 reaction mixture Substances 0.000 description 11
238000003018 immunoassay Methods 0.000 description 10
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
238000003556 assay Methods 0.000 description 9
238000001514 detection method Methods 0.000 description 9
238000012360 testing method Methods 0.000 description 9
230000004913 activation Effects 0.000 description 8
239000012153 distilled water Substances 0.000 description 8
239000000203 mixture Substances 0.000 description 8
239000013610 patient sample Substances 0.000 description 7
PFKFTWBEEFSNDU-UHFFFAOYSA-N 1,1'-Carbonyldiimidazole Substances C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 6
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
229920002125 Sokalan® Polymers 0.000 description 6
239000008351 acetate buffer Substances 0.000 description 6
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 6
238000001948 isotopic labelling Methods 0.000 description 6
239000000463 material Substances 0.000 description 6
230000009871 nonspecific binding Effects 0.000 description 6
229920000642 polymer Polymers 0.000 description 6
229920001917 Ficoll Polymers 0.000 description 5
229940074608 allergen extract Drugs 0.000 description 5
238000004458 analytical method Methods 0.000 description 5
230000000694 effects Effects 0.000 description 5
238000005259 measurement Methods 0.000 description 5
230000004048 modification Effects 0.000 description 5
238000012986 modification Methods 0.000 description 5
239000008363 phosphate buffer Substances 0.000 description 5
229920002401 polyacrylamide Polymers 0.000 description 5
239000004584 polyacrylic acid Substances 0.000 description 5
230000035945 sensitivity Effects 0.000 description 5
AYXZIZMZXAORLO-UFLZEWODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid;1-hydroxypyrrolidine-2,5-dione Chemical compound ON1C(=O)CCC1=O.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 AYXZIZMZXAORLO-UFLZEWODSA-N 0.000 description 4
229910014033 C-OH Inorganic materials 0.000 description 4
229910014570 C—OH Inorganic materials 0.000 description 4
108010020346 Polyglutamic Acid Proteins 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
238000002835 absorbance Methods 0.000 description 4
239000000872 buffer Substances 0.000 description 4
238000000502 dialysis Methods 0.000 description 4
229920002643 polyglutamic acid Polymers 0.000 description 4
229920001184 polypeptide Polymers 0.000 description 4
108090000765 processed proteins & peptides Proteins 0.000 description 4
102000004196 processed proteins & peptides Human genes 0.000 description 4
238000000926 separation method Methods 0.000 description 4
238000012882 sequential analysis Methods 0.000 description 4
229910000033 sodium borohydride Inorganic materials 0.000 description 4
239000012279 sodium borohydride Substances 0.000 description 4
229920002307 Dextran Polymers 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
108060003951 Immunoglobulin Proteins 0.000 description 3
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
239000002253 acid Substances 0.000 description 3
235000004279 alanine Nutrition 0.000 description 3
239000011324 bead Substances 0.000 description 3
229940098773 bovine serum albumin Drugs 0.000 description 3
230000008878 coupling Effects 0.000 description 3
238000010168 coupling process Methods 0.000 description 3
238000005859 coupling reaction Methods 0.000 description 3
102000018358 immunoglobulin Human genes 0.000 description 3
238000013198 immunometric assay Methods 0.000 description 3
230000001939 inductive effect Effects 0.000 description 3
KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 3
-1 polyethylene Polymers 0.000 description 3
235000017557 sodium bicarbonate Nutrition 0.000 description 3
229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
239000000243 solution Substances 0.000 description 3
SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 description 2
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
235000018185 Betula X alpestris Nutrition 0.000 description 2
235000018212 Betula X uliginosa Nutrition 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
RZZPDXZPRHQOCG-OJAKKHQRSA-O CDP-choline(1+) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-O 0.000 description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
108010001336 Horseradish Peroxidase Proteins 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
239000004472 Lysine Substances 0.000 description 2
241000746983 Phleum pratense Species 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
150000001413 amino acids Chemical class 0.000 description 2
230000008901 benefit Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
235000014633 carbohydrates Nutrition 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
229960001760 dimethyl sulfoxide Drugs 0.000 description 2
230000007717 exclusion Effects 0.000 description 2
238000002875 fluorescence polarization Methods 0.000 description 2
235000013922 glutamic acid Nutrition 0.000 description 2
239000004220 glutamic acid Substances 0.000 description 2
229940072221 immunoglobulins Drugs 0.000 description 2
238000011534 incubation Methods 0.000 description 2
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
239000011734 sodium Substances 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
238000003746 solid phase reaction Methods 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
239000012224 working solution Substances 0.000 description 2
GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
241000283707 Capra Species 0.000 description 1
229920002271 DEAE-Sepharose Polymers 0.000 description 1
ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
108060003393 Granulin Proteins 0.000 description 1
108091006905 Human Serum Albumin Proteins 0.000 description 1
102000008100 Human Serum Albumin Human genes 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
101150046432 Tril gene Proteins 0.000 description 1
101000654530 Tupaia virus (isolate Tupaia/Thailand/-/1986) Small hydrophobic protein Proteins 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
230000002009 allergenic effect Effects 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
230000007815 allergy Effects 0.000 description 1
238000012870 ammonium sulfate precipitation Methods 0.000 description 1
230000001745 anti-biotin effect Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
108091006004 biotinylated proteins Proteins 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
229910021538 borax Inorganic materials 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000012876 carrier material Substances 0.000 description 1
238000001023 centrifugal evaporation Methods 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
229940089960 chloroacetate Drugs 0.000 description 1
FOCAUTSVDIKZOP-UHFFFAOYSA-M chloroacetate Chemical compound [O-]C(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-M 0.000 description 1
FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
229940106681 chloroacetic acid Drugs 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
238000002967 competitive immunoassay Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
230000007423 decrease Effects 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
238000009585 enzyme analysis Methods 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
230000036541 health Effects 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
239000003547 immunosorbent Substances 0.000 description 1
238000005372 isotope separation Methods 0.000 description 1
238000002386 leaching Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
229940045641 monobasic sodium phosphate Drugs 0.000 description 1
229910000403 monosodium phosphate Inorganic materials 0.000 description 1
235000019799 monosodium phosphate Nutrition 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
239000012071 phase Substances 0.000 description 1
238000005191 phase separation Methods 0.000 description 1
239000002953 phosphate buffered saline Substances 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
238000000163 radioactive labelling Methods 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 description 1
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
235000010339 sodium tetraborate Nutrition 0.000 description 1
238000002764 solid phase assay Methods 0.000 description 1
241000894007 species Species 0.000 description 1
229940043517 specific immunoglobulins Drugs 0.000 description 1
238000003756 stirring Methods 0.000 description 1
230000008685 targeting Effects 0.000 description 1
238000010998 test method Methods 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
- G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/548—Carbohydrates, e.g. dextran
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/805—Test papers
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/971—Capture of complex after antigen-antibody reaction
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/823—Immunogenic carrier or carrier per se

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Food Science & Technology (AREA)
General Physics & Mathematics (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Pathology (AREA)
Chemical Kinetics & Catalysis (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Materials By Optical Means (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Investigating Or Analysing Biological Materials (AREA)

DK241787A 1986-05-12 1987-05-12 Fremgangsmåde til måling af niveauet af antigener,antistoffer eller haptener i en flydende prøve DK169364B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US86212386		1986-05-12
US06/862,123 US4778751A (en)	1986-05-12	1986-05-12	Method for measuring antigens or antibodies in biological fluids using ligand labeled antigens or ligand labeled antibodies

Publications (3)

Publication Number	Publication Date
DK241787D0 DK241787D0 (da)	1987-05-12
DK241787A DK241787A (da)	1987-11-13
DK169364B1 true DK169364B1 (da)	1994-10-10

Family

ID=25337725

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK241787A DK169364B1 (da)	1986-05-12	1987-05-12	Fremgangsmåde til måling af niveauet af antigener,antistoffer eller haptener i en flydende prøve

Country Status (12)

Country	Link
US (1)	US4778751A (de)
EP (1)	EP0245926B1 (de)
JP (2)	JPH0721500B2 (de)
AT (1)	ATE72336T1 (de)
AU (1)	AU613308B2 (de)
CA (1)	CA1291028C (de)
DE (1)	DE3776401D1 (de)
DK (1)	DK169364B1 (de)
IE (1)	IE59362B1 (de)
IL (1)	IL82466A (de)
NO (1)	NO169511C (de)
NZ (1)	NZ218981A (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3705686C2 (de) *	1987-02-23	1995-11-30	Boehringer Mannheim Gmbh	Verfahren zur Bestimmung von Antikörpern
DE3804244A1 (de) *	1987-12-24	1989-07-06	Boehringer Mannheim Gmbh	Verfahren zur bestimmung einer immunologisch aktiven substanz
DE3806431A1 (de) *	1988-02-29	1989-09-07	Boehringer Mannheim Gmbh	Verfahren zur herstellung einer festphasenmatrix
US5268306A (en) *	1988-02-29	1993-12-07	Boehringer Mannheim Gmbh	Preparation of a solid phase matrix containing a bound specific binding pair
WO1989010974A1 (en) *	1988-05-11	1989-11-16	Trustees Of The Sisters Of Charity Of Australia	Enzyme immunoassay system
AU2684488A (en) *	1988-06-27	1990-01-04	Carter-Wallace, Inc.	Test device and method for colored particle immunoassay
US5277589A (en) *	1988-07-08	1994-01-11	Boehringer Mannheim Gmbh	Process for the determination of antibodies
DE3907651A1 (de) *	1988-07-08	1990-01-11	Boehringer Mannheim Gmbh	Verfahren zur bestimmung von antikoerpern
US5888728A (en)	1988-10-17	1999-03-30	Molecular Devices Corporation	Hapten derivatized capture membrane and diagnostic assays using such membrane
DE3836348A1 (de) *	1988-10-25	1990-04-26	Boehringer Mannheim Gmbh	Verfahren zur bestimmung von fuer ein antigen klassenspezifischen antikoerpern und dazu geeignetes reagenz
DE3840605A1 (de) *	1988-12-02	1990-06-07	Behringwerke Ag	Mittel fuer immunchemische tests enthaltend carboxylgruppenhaltige polymere
GB2226032B (en) *	1988-12-16	1993-08-18	Urs Heimgartner	Detection of glycoproteins
US5028535A (en) *	1989-01-10	1991-07-02	Biosite Diagnostics, Inc.	Threshold ligand-receptor assay
CA2008100A1 (en) *	1989-01-20	1990-07-20	Hubert Bayer	Method for the determination of immunologically detectable substance
AU5921690A (en) *	1989-05-24	1990-12-18	Ensys, Inc.	Method and apparatus for detecting environmental contaminants
JP2619549B2 (ja) *	1989-06-29	1997-06-11	日本商事株式会社	抗原の定量法およびそれに用いる固相
CA1341592C (en) *	1989-07-07	2009-04-14	Abbott Laboratories	Ion capture reagents and methods for performing binding assays
US5141850A (en) *	1990-02-07	1992-08-25	Hygeia Sciences, Inc.	Porous strip form assay device method
US5206179A (en) *	1991-03-25	1993-04-27	Abbott Laboratories	Fluorescence polarization immunoassays for multiple analytes using sequential addition of tracers
EP0594772B1 (de) *	1991-07-04	1996-08-28	Immunodex K/S	Wasserlösliche reagenzien und konjugate auf polymerbasis, die vom divinylsulfon abgeleitete reste enthalten
DK130991D0 (da) *	1991-07-04	1991-07-04	Immunodex K S	Polymere konjugater
GB9122180D0 (en)	1991-10-18	1991-11-27	Marconi Gec Ltd	Separation and analysis
DE4140142A1 (de) *	1991-12-05	1993-06-09	Boehringer Mannheim Gmbh, 6800 Mannheim, De	Multivalentes dextranreagenz zum einsatz in praezipitationstests
CA2141428A1 (en) *	1992-07-28	1994-02-03	Steven Kessler	Methods for positive immunoselection of stem cells
ATE244406T1 (de) *	1993-05-10	2003-07-15	Nissui Pharm Co Ltd	Verfahren zur bestimmung von mehr als einem immunologischen liganden und bestimmungsreagenz sowie satz dafuer
US5518882A (en) *	1993-12-21	1996-05-21	Biotex Laboratories, Inc.	Immunological methods of component selection and recovery
US20010051350A1 (en) *	1995-05-02	2001-12-13	Albert Nazareth	Diagnostic detection device and method
EP0824596A1 (de) *	1995-05-12	1998-02-25	Schering Corporation	Auf oberflächenplasmonresonanz basierende enzymatische bestimmung
US5780319A (en) *	1996-04-19	1998-07-14	Pasteur Sanofi Diagnostics	Immunoassays to detect antiphospholipid antibodies
US5776487A (en) *	1996-04-19	1998-07-07	Pasteur Sanofi Diagnostics	Liposome reagents for immunoassays
US6271044B1 (en)	1998-05-06	2001-08-07	University Of Pittsburgh Of The Commonwealth System Of Higher Education	Method and kit for detecting an analyte
US6303325B1 (en)	1998-05-29	2001-10-16	Dade Behring Inc.	Method for detecting analytes
JP4004230B2 (ja) *	1998-11-06	2007-11-07	株式会社三菱化学ヤトロン	架橋アビジン含有新規複合体、架橋アビジンを用いる分析方法、並びに分析用試薬及びキット
US6989247B2 (en)	2000-11-28	2006-01-24	Celltech R & D, Inc.	Compositions and methods for diagnosing or treating psoriasis
US7393921B2 (en) *	2000-12-04	2008-07-01	Institute For Systems Biology	Prostate-specific polypeptide pamp and encoding nucleic acid molecules
US7071303B2 (en)	2001-03-28	2006-07-04	Institute For Systems Biology	Androgen regulated prostate specific nucleic acids
US7262019B2 (en) *	2001-05-03	2007-08-28	Immunetics, Inc.	System and methods for detection of Bacillus anthracis related analytes in biological fluids
US7105311B2 (en) *	2001-05-03	2006-09-12	Immunetics, Inc.	Systems and methods for detection of analytes in biological fluids
US20040137440A1 (en) *	2002-01-15	2004-07-15	Biaoyang Lin	Androgen regulated nucleic acid molecules and encoded proteins
US7704700B2 (en) *	2002-02-12	2010-04-27	Burnham Institute For Medical Research	Methods for determining the prognosis for patients with a prostate neoplastic condition using inhibitor of apoptosis polypeptides
EP1489420A4 (de) *	2002-03-07	2006-05-03	Enbiotec Lab Co Ltd	Instrumente zum nachweis einer niedermolekularen substanz
GB2400851B (en) *	2003-04-25	2004-12-15	Bioinvent Int Ab	Identifying binding of a polypeptide to a polypeptide target
CA2547353A1 (en) *	2003-12-01	2005-07-07	Dade Behring Marburg Gmbh	Conjugates, and use thereof in detection methods
US20050118727A1 (en) *	2003-12-01	2005-06-02	Carsten Schelp	Conjugates and their use in detection methods
EP1695083A1 (de)	2003-12-01	2006-08-30	Dade Behring Marburg GmbH	Homogenes nachweisverfahren
DE102004005710A1 (de) *	2004-02-05	2006-05-04	Siemens Ag	Biosensor und Verfahren zu dessen Betrieb
DE102004005711A1 (de) *	2004-02-05	2006-05-11	Siemens Ag	Biosensor zur Bestimmung eines Allergenes mit Betriebsverfahren
DE602005023624D1 (de)	2004-07-30	2010-10-28	Advanced Life Science Inst Inc	Sondenkomplex
DE102005026839A1 (de) *	2005-06-10	2006-12-21	Universität Tübingen	Verfahren und Vorrichtung zur quantitativen Bestimmung von Analyten in flüssigen Proben
AU2007217765A1 (en) *	2006-02-21	2007-08-30	Nanogen, Inc.	Methods and compositions for analyte detection
EP1930729A1 (de) *	2006-12-04	2008-06-11	Medizinische Universität Wien	Verfahren für in vivo und in vitro Tests für von pharmazeutischen Arzneimitteln induzierten Überempfindlichkeitsreaktionen vom Soforttyp
US20080213797A1 (en) *	2007-03-01	2008-09-04	Abbott Laboratories	Immunoassays exhibiting a reduction in prozone phenomena
EP2404162B1 (de)	2009-03-03	2017-12-27	Access Medical System Co., Ltd.	Nachweissystem und verfahren für hochsensitive fluoreszenztests
US9733242B2 (en) *	2012-10-07	2017-08-15	Sevident, Inc.	Devices for capturing analyte
CN107462707A (zh) *	2009-11-24	2017-12-12	赛维登特公司	用于检测分析物的装置
US9910040B2 (en) *	2012-07-09	2018-03-06	Sevident, Inc.	Molecular nets comprising capture agents and linking agents
US8486717B2 (en)	2011-01-18	2013-07-16	Symbolics, Llc	Lateral flow assays using two dimensional features
CN103608675B (zh)	2011-04-20	2015-07-22	万迈医疗仪器有限公司	发光聚合物循环扩增
WO2013021277A1 (en)	2011-08-10	2013-02-14	Indian Immunologicals Limted	Recombinant ant-bovine iga antibody and uses thereof
US9568431B2 (en)	2012-04-16	2017-02-14	Access Medical Systems, Ltd.	Luminescent immunoassays for quantitating analytes having a wide concentration range
US9874556B2 (en) *	2012-07-18	2018-01-23	Symbolics, Llc	Lateral flow assays using two dimensional features
EP3933384A1 (de)	2013-03-15	2022-01-05	Hycor Biomedical, LLC	Vorrichtung und zugehöriges verfahren zur durchführung von lumineszenz- und fluoreszenzmessungen in einer probe
EP3044592B1 (de)	2013-09-13	2019-07-17	Symbolics, LLC	Lateral-flow-tests mit zweidimensionalen test- und steuersignalauslesemustern
CZ308807B6 (cs)	2015-01-14	2021-06-02	Ústav Organické Chemie A Biochemie Av Čr, V.V.I.	Makromolekulární konjugáty pro vizualizaci a separaci proteinů a buněk
CZ308742B6 (cs)	2015-01-14	2021-04-21	Ústav Organické Chemie A Biochemie Av Čr, V.V.I.	Makromolekulární konjugáty pro izolaci, imobilizaci a vizualizaci proteinů
WO2020074863A1 (en) *	2018-10-08	2020-04-16	Applied Photophysics Limited	System and method for analysing the composition of a quenched flow reaction liquid
JP7493513B2 (ja)	2018-12-28	2024-05-31	アボット・ラボラトリーズ	微粒子上の１分子の直接検出

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3720760A (en) *	1968-09-06	1973-03-13	Pharmacia Ab	Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples
NL7501215A (nl) *	1975-02-01	1976-08-03	Akzo Nv	Methode voor het aantonen en bepalen van een antigeen of antilichaam.
AU510210B2 (en) *	1976-05-03	1980-06-12	Beckman Instruments, Inc	Immunoassay procedure employing novel immunochemical composites
US4495296A (en) *	1979-05-21	1985-01-22	New York Blood Center, Inc.	Labeled anti-hapten antibodies and their use as a universal reagent for solid phase radio- and/or enzyme-immunoassays
US4281061A (en) *	1979-07-27	1981-07-28	Syva Company	Double antibody for enhanced sensitivity in immunoassay
US4401764A (en) *	1980-02-07	1983-08-30	Technicon Instruments Corporation	Immunoassays employing labeled reagent and a conjugate having two binding sites
GB2084317B (en) *	1980-09-30	1984-01-18	Erba Farmitalia	Antigen-linked competitive enzymeimmunoassay
IE54109B1 (en) *	1982-02-10	1989-06-21	Boots Celltech Diagnostics	Assay
US4506009A (en) *	1982-03-30	1985-03-19	University Of California	Heterogeneous immunoassay method
US4522922A (en) *	1982-04-16	1985-06-11	Jose Carro	Soluble assay
US4530900A (en) *	1982-09-13	1985-07-23	Seragen Diagnostics Inc.	Soluble insoluble polymers in enzymeimmunoassay
US4496654A (en) *	1983-04-08	1985-01-29	Quidel	Detection of HCG with solid phase support having avidin coating
GB8311136D0 (en) *	1983-04-25	1983-06-02	Lepetit Spa	Immobilised oligopeptides
US4595661A (en) *	1983-11-18	1986-06-17	Beckman Instruments, Inc.	Immunoassays and kits for use therein which include low affinity antibodies for reducing the hook effect
GB8422452D0 (en) *	1984-09-05	1984-10-10	Serono Diagnostics Ltd	Assay

1986
- 1986-05-12 US US06/862,123 patent/US4778751A/en not_active Expired - Lifetime
1987
- 1987-01-16 AU AU67620/87A patent/AU613308B2/en not_active Expired
- 1987-01-20 IE IE13587A patent/IE59362B1/en not_active IP Right Cessation
- 1987-01-20 NZ NZ218981A patent/NZ218981A/xx unknown
- 1987-01-22 CA CA000527895A patent/CA1291028C/en not_active Expired - Lifetime
- 1987-02-19 NO NO870670A patent/NO169511C/no unknown
- 1987-02-27 JP JP62045095A patent/JPH0721500B2/ja not_active Expired - Lifetime
- 1987-03-06 EP EP87301978A patent/EP0245926B1/de not_active Expired - Lifetime
- 1987-03-06 DE DE8787301978T patent/DE3776401D1/de not_active Expired - Lifetime
- 1987-03-06 AT AT87301978T patent/ATE72336T1/de not_active IP Right Cessation
- 1987-05-10 IL IL82466A patent/IL82466A/xx unknown
- 1987-05-12 DK DK241787A patent/DK169364B1/da not_active IP Right Cessation
1994
- 1994-08-24 JP JP6199967A patent/JPH081437B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NO870670L (no)	1987-11-13
IL82466A (en)	1991-12-12
DK241787A (da)	1987-11-13
AU6762087A (en)	1987-11-19
IL82466A0 (en)	1987-11-30
EP0245926A3 (en)	1988-05-25
EP0245926B1 (de)	1992-01-29
JPH081437B2 (ja)	1996-01-10
IE59362B1 (en)	1994-02-09
AU613308B2 (en)	1991-08-01
DE3776401D1 (de)	1992-03-12
NZ218981A (en)	1989-08-29
ATE72336T1 (de)	1992-02-15
JPH07239331A (ja)	1995-09-12
US4778751A (en)	1988-10-18
NO870670D0 (no)	1987-02-19
EP0245926A2 (de)	1987-11-19
JPS62269070A (ja)	1987-11-21
JPH0721500B2 (ja)	1995-03-08
CA1291028C (en)	1991-10-22
NO169511C (no)	1992-07-01
IE870135L (en)	1987-11-12
NO169511B (no)	1992-03-23
DK241787D0 (da)	1987-05-12

Legal Events

Date	Code	Title	Description
1994-10-10	B1	Patent granted (law 1993)
2007-05-29	PUP	Patent expired

Publication	Publication Date	Title
DK169364B1 (da)	1994-10-10	Fremgangsmåde til måling af niveauet af antigener,antistoffer eller haptener i en flydende prøve
US4298685A (en)	1981-11-03	Diagnostic reagent
O'sullivan et al.	1979	Enzyme immunoassay: a review
CA2014318C (en)	2000-08-08	Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay
US4629692A (en)	1986-12-16	Immunoassay for nonenzymatically glucosylated proteins and protein fragments an index of glycemia
Avrameas et al.	1972	Enzyme-immunoassay for the measurement of antigens using peroxidase conjugates
US5851778A (en)	1998-12-22	Analyte assay using a trifunctional conjugate
EP0075193B1 (de)	1985-08-28	Verfahren zur Bestimmung von Pregnandiolglucuronid und dafür verwendeter Indikatorstreifen
EP0269451A2 (de)	1988-06-01	Markierungsentwurf für ein Bindungstestreagens
EP0317796B1 (de)	1992-09-30	Herstellung von Ligand-Polymer-Konjugat mit einer kontrollierten Zahl von eingeführten Liganden
JPH05504841A (ja)	1993-07-22	リガンドレセプター及びリガンドのコンプレックスに対する抗体及びリガンド―レセプターアッセーでのそれらの用途
US4975532A (en)	1990-12-04	Method to derivatize dextran
JPS63163166A (ja)	1988-07-06	不均質免疫学的測定試験に用いるための安定な固定化ハプテン試薬及びその製造方法並びに用途
JPH02228561A (ja)	1990-09-11	免疫学的に検出可能の物質を測定する方法および試薬
EP0653065B1 (de)	2002-10-30	Trennverfahren
USRE32557E (en)	1987-12-08	Method of determining pregnanediol in female urine and test device for use therein
AU739280B2 (en)	2001-10-11	Receptor: release ligand (reland) complexes and assays and kits based thereon
JPH01232263A (ja)	1989-09-18	トリヨードサイロニン摂取率免疫測定法
GB2273157A (en)	1994-06-08	Immunological detection/separation using a plurality of immobilised binding agents
JPS60138462A (ja)	1985-07-23	抗原カラムを用いる抗原の定量法